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ABSTRACT
Herpes simplex virus type-1 (HSV-1) causes a variety of diseases in human. This virus is a neurotropic 
pathogen of human that establishes latent infection in the sensory ganglia innervating the site of 
primary infection. A number of genes including ICP34.5 control HSV-1 pathogenicity and ICP34.5 has 
been identified as HSV-1 virulence gene. Open reading frame P (ORF P) is also a HSV-1 gene that 
might have a role in latency. A complication in the analysis of the role of ICP34.5 and ORF P in the 
HSV-1 life cycle is that these two are overlapping antisense genes. ORF P is also deleted in ICP34.5
negative mutants and to date, no definite function is attributed to it. To attribute characteristics which 
were originally attributed solely to ICP34.5 to each of these two genes (ORF P or ICP34.5), an 
approach is to construct a number of HSV-1 recombinant viruses that express ICP34.5 and ORF P 
independently. An alternative way is to determine if ORF P interacts with any of the cellular and viral 
proteins both in vitro and in vivo. Using Glutathione-S-transferase (GST) pulldown assay and 
Western-blotting, we showed that ORF P interacts with a cellular splicing factor (SC35) in vitro. To 
investigate the colocalization of ORF P and SC35, nuclear and cytoplasmic fractionation of ORF 
P/SC35 was also carried out. Our results showed that both SC35 and ORF P are located in the nucleus 
of HSV-1 infected cells. Conclusively, because ORF P interacts and colocalizes with SC35, it might 
have a role in splicing.  Iran. Biomed. J. 9 (2): 67-71, 2005
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INTRODUCTION
erpes simplex virus type-1 (HSV-1) is a 
neurotropic pathogen of humans that 
establishes latent infection in the sensory 
ganglia innervating the site of primary infection [1]. 
There are a number of genes which are involved in 
virus pathogenicity and latency [1]. A major focus 
of investigations into genes controlling the 
establishment or maintenance of latency has been 
the latency associated transcripts (LAT). These 
transcripts arise from the HSV inverted repeats 
flanking the UL sequence and therefore present in 2
copies per viral genome [1, 2]. The HSV-1
unspliced 8.3 kb LAT has been shown to contain at 
least 16 open reading frames (ORF) [3]. 
One of these ORF is ORF P, which is shown to 
encode a protein [3-5]. ORF P expressed by HSV-1
strain (F) and (17+) is predicted to contain 248 and 
233 amino acids, respectively [3]. It is located in the 
3' domain of LAT, almost entirely antisense to the 
ICP34.5 gene and is also contained at 5' end of the 
long/short transcripts (L/ST) [3, 5]. The role of ORF 
P in HSV-1 life cycle is not known and no definite 
function has been attributed to it except the possible 
role in splicing at early times in infection and in 
latency [5-8]. The most striking feature of ORF P is 
nearly completely overlapped by ICP34.5 gene [3].
ICP34.5 is a HSV-1 neurovirulence gene that is 
essential in vivo and located in the long repeat 
region of the HSV-1 genome [9].
To determine the role of ICP34.5 in the HSV-1
(17+) life cycle, a number of ICP34.5 deletion 
mutants have been characterized. These null 
mutants are unable to replicate in the central 
nervous system of mice and are totally avirulent 
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with a LD50 of 10
6 pfu/mouse higher than wild type 
or rescued virus [10]. In tissue culture, these null 
mutants replicate normally in many non-neuronal 
cell types such as Vero and BHK 21/C13 cells, but 
are restricted in SK-N-SH neuroblastoma, human 
foreskin fibroblast (HFF), murine 10T1/2 cells, 
stationary phase primary mouse embryo and mouse 
embryo fibroblast (3T6) cells [9, 11, 12].
As most ICP34.5 null mutants affect ORF P due 
to the extensive overlap of their sequences, it was 
difficult to assign a role to ORF P. To assign the 
phenotypes of these mutants to either ICP34.5 or 
ORF P, an approach is to construct a number of 
recombinant viruses expressing only ICP34.5 or 
ORF P at separated loci and the phenotypes of these 
recombinants to be analysed. An alternative way to 
analyze the function of a viral gene such as ORF P 
is to determine if this gene interacts with any of the 
cellular and viral proteins both in vitro and in vivo. 
Therefore, using GST pulldown assay and Western-
blotting, it was investigated that with which cellular 
and viral gene products ORF P interacts. The only 
identified cellular protein interacting in vitro with 
ORF P detected in these experiments was SC35. To 
investigate the colocalization of ORF P and SC35, 
nuclear and cytoplasmic fractionation of ORF 
P/SC35 was also carried out.
MATERIALS AND METHODS
Cells.  Baby hamster kidney 21 clone 13 (BHK) 
cells [13] were grown in Eagle’s medium 
supplemented with 10% (v/v) newborn calf serum.   
Viruses.  The wild type virus used was HSV-1
17+ [14]. The HSV-1 17+ ICP34.5/ORF P deletion 
variant 1716 [15] was used as a negative control. 
TsK, a HSV-1 17+ mutant with a ts lesion in ICP4
[16], which results in overproduction of ORF P at 
the non-permissive temperature, was also used.
Nuclear and cytoplasmic fractionation of ORF 
P/SC35.  Virus infected cells were washed twice 
with PBS A (170 mM NaCl, 3.4 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4, pH 7.2) and harvested 
by scraping the monolayer into PBS A containing 
Eppendorf tube. To extract the cytoplasmic fraction, 
cell suspension was briefly vortexed and spun and 
cell pellet was resuspended in 100 # 1 buffer A 
(50 mM Tris HCl, 5 mM MgCl2, 10% (v/v) NP40, 
pH 7.5) containing 0.5% (v/v) NP40, incubated on 
ice for 15 min and then homogenized on ice in a 
Dounce homogenizer (Sigma, USA). The samples 
were centrifuged and the supernatant was kept on 
ice while the pellet was resuspended with 100 1
buffer A containing 0.5% (v/v) NP40, incubated on 
ice for 2-3 min, spun and then supernatant mixed 
with the previous supernatant and used as the 
cytoplasmic fraction [17]. 
To extract the nuclear fraction, the infected 
monolayer was scraped into Falcon tube containing 
10 ml PBS A, briefly vortexed and spun. The cell 
pellet was resuspended in 4 ml hypotonic lysis 
buffer (HLB) (10 mM Tris HCl, 10 mM KCl, 2.5
mM MgCl2, pH 7.5) and incubated on ice for 15
min. After incubation, the samples were centrifuged 
and the supernatant was left on ice while the pellet 
was resuspended with 1 ml supernatant and 
homogenized on ice in a Dounce homogenizer 
(Sigma, USA). The homogenized solution was 
mixed with the rest of the supernatant in a 15 ml 
Falcon tube, underlayed with 1 ml HLB + 10%
(w/v) sucrose and respun at 3600 g for 5 min at 
4C. The supernatant was discarded and the pellet 
containing the nuclei resuspended in 100 µ1 boiling 
mix [17]. Samples were boiled for 10 min and 
analyzed by SDS-PAGE and Western-blotted.
Western-blotting.  Samples were separated by 
SDS-PAGE. The proteins in the gel were 
transferred into the membrane. After the transfer, 
the membrane was blocked in PBS A containing 
Tween 20 (PBS A/T) and in dried milk at room 
temperature for 1 h. The primary antibody was 
incubated either at 37C or room temperature for 2
h and at 4C overnight. The membrane was washed 
3 times in PBS A/T at room temperature for 10 min 
and then incubated at room temperature for 1 h in 
the appropriate HRP conjugated secondary antibody 
followed by 3 washes in PBS A/T for 10 min. A 
chemiluminescence detection reagent (ECL, Sigma, 
USA) was added to the membrane for 1 min and the 
membrane was exposed to XS-1 film for the 
appropriate amount of time [18].
Immunoprecipitation.  Virus infected monolayers 
were harvested by washing with PBS A twice, 
adding 500 l Zweig's buffer (0.1 M Tris HCl, 10%
(w/v) glycerol, 0.5% (w/v) NP40, 0.5% (w/v) 
deoxycholate, pH 8.5) to each plate and incubating 
at 4C for 60 min. The extracted cells were 
sonicated for 3 min and spun at 13225 g for 3 min. 
The supernatant was used immediately or stored at 
-70C. The supernatant of the cell extract (200-500
1) was mixed with the appropriate volume of 
antibody and incubated either at 4oC overnight or at 
37C for 2 h. Protein-A-sepharose (75 µ1 50%
[v/v]), in Zweig's buffer was added and the sample 
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was incubated on an end-over-end mixer at 4C for 
45 min. After that, the sample was centrifuged at 
3,800 g for 1 min, the supernatant was discarded 
and the pellet was washed 3-4 times with Zweig's 
buffer. After the final wash, the pellet was harvested 
in 50 µ1 boiling mixture and analyzed by SDS-
PAGE [19].
Pulldown assay. Freshly prepared glutathione 
agarose beads, bound to GST fusion proteins, were 
mixed with 300 or 400 1 labelled or unlabelled 
cell protein extract and incubated at 4C for at least 
3 h with continuous end-over-end mixing. The 
beads were harvested by centrifugation at 13,225 g 
for 1 min and washed 3 times in 1 ml of an 
extraction buffer (50 mM NaCl, 0.1% (v/v) NP40, 
pH 7.5) containing different amounts of NaCl (0.5-
500 # mM). Again, they were harvested in boiling 
mixture, stored either at -20C or boiled for 5 min 
and analyzed by SDS-PAGE [20]. Gels were either 
fixed, dried and autoradiographed or used for 
Western-blotting.
RESULTS
In vitro interaction of HSV-1 ORF P with a 
cellular splicing factor (SC35).  GST pulldown is a 
method usually used to determine protein-protein 
interactions in vitro. This method was used in this 
work to determine the interaction of ORF P with 
cellular and viral proteins. Using a GST pulldown 
assay, we previously showed that ORF P interacts 
with a number of cellular proteins (personal data). 
Therefore, the GST pulldowns were screened with a 
range of antibodies against proteins with some role 
in splicing and posttranscriptional processing and 
were of an appropriate molecular weight which 
could identified in the gel (pulldown experiments). 
Western-blotting of cellular extracts was carried out 
with these antibodies (Ab against above mentioned 
proteins). The only identified cellular protein 
interacting with ORF P detected in these 
experiments was SC35. Figure 1 shows Western-
blotting of GST and GST-ORF P pulldown extracts 
with an antibody against SC35. As expected, the 
specific 65 kDa, SC35 band was detected in both 
mock infected (lane 6) and 17+ (lane 3) cell extracts. 
The 65 kDa SC35 band was detected specifically in 
the GST-ORF P pulldowns (lanes 2 and 5) but not 
in GST pulldowns (lanes 1 and 4). 
Fig. 1. Western-blotting of GST-ORF P pulldown with an 
antibody against SC35. GST pulldown extracts were run on a 
12.5% SDS-PAGE and analyzed by Western-blotting using an 
antibody against SC35. Lanes 1–3: 17+ infected cell extracts; 
lane 1, 17+/GST pulldown; lane 2, 17+/GST-ORF P pulldown; 
lane 3, whole 17+ infected cell extracts; lanes 4-6, MI extract; 
lane 4, MI/GST pulldown; lane 5, MI/GST-ORF P pulldown; 
lane 6, whole MI cell extracts. SC35 band is indicated (). 
Molecular weights are marked (). 
Colocalization: nuclear and cytoplasmic 
fractionation of SC35/ORF P.  Our results have 
demonstrated that ORF P interacts in vitro with 
SC35.  If  this  was representative  of   an   in  vivo
interaction, it would be expected that both proteins 
would be located in the same cellular compartment. 
To investigate the intracellular location of ORF P 
and SC35, BHK cells were infected with tsK, 17+
and 1716 or mock infected and their nuclear and 
cytoplasmic proteins were separately extracted and 
Western blotted with both antibody against SC35
and antiserum 128 against ORF P. Figure 2 shows 
Western-blotting of nuclear and cytoplasmic 
extracts with an antibody against SC35. SC35 is 
located in the nucleus of tsK (lane 1), 17+ (lane 3), 
1716 (lane 5) and mock infected (lane 7) and BHK 
cells with no protein were detected in the cytoplasm 
(lanes 2, 4, 6 and 8).
Figure 3 shows the Western-blotting of nuclear 
and cytoplasmic extracts with antiserum 128. ORF 
P located in approximately equal amounts in both 
the nucleus and cytoplasm of BHK cells were 
infected with tsK (lanes 1 and 2) and 17+ (lanes 3
and 4). As expected, no ORF P was detected in 
1716 (lanes 5 and 6) or mock infected (lanes 7 and
8) extracts. In lane 9, a whole cell extract from tsK-
infected BHK cells was used as a positive control to 
show the 30 kDa ORF P protein.
D
ow
nl
oa
de
d 
fro
m
 ib
j.p
as
teu
r.a
c.i
r a
t 1
4:1
0 I
RD
T o
n M
on
da
y A
ug
us
t 2
1s
t 2
01
7
Karimi & Salehi
70
Fig. 2. Western blotting of BHK nuclear and cytoplasmic 
extracts with SC35 antibody. BHK cells were infected with
HSV-1 at a multiplicity of infection (m.o.i) of 20 pfu/cell and 
harvested at 24 h post infection (pi). Analysis of SC35
distribution in both BHK cell nuclear and cytoplasmic extracts 
was carried out by 7.5% SDS-PAGE and Western-blotting with 
SC35 antibody and anti IgG-HRP, reacted with ECL and 
exposed to autoradiography.  Lanes 1, 3, 5 and 7, nuclear 
extracts; lanes 2, 4, 6 and 8, cytoplasmic extracts. Lanes 1 and 
2, tsK; lanes 3 and 4, 17+; lanes 5 and 6, 1716; lanes 7 and 8, 
MI. Molecular weight markers are indicated on the right and 
SC35 related bands are marked on the left ().
DISCUSSION
The only characterized cellular protein interacting 
with ORF P detected in these experiments was 
SC35. SC35 is an essential component of small 
non-nuclear ribonucleoprotein particles and is a 
splicing factor [21-23]. Previously was shown that 
ORF P interacts with a number of splicing factors 
and may play a role in splicing [21]. Having 
demonstrated that ORF P interacted in vitro with 
SC35, we wished to determine if this was 
representative of an in vivo interaction. To occur 
this, it would be expected that both proteins would 
be located in the same cellular compartment. It has 
previously been demonstrated that SC35 localizes 
mainly to the nucleus [17] and thus we wished to 
confirm this and determine if ORF P was also 
located in the nucleus. To investigate the 
intracellular location of ORF P and SC35, BHK 
cells were infected with tsK and 17+, their nuclear 
and cytoplasmic proteins were extracted separately 
and Western-blotted with antisera against SC35 and 
ORF P.
As previously published, SC35 is located in the 
cell nucleus with no protein being detected in the 
cytoplasm [17]. ORF P is located in approximately 
equal amounts in both the nucleus and cytoplasm of 
the infected BHK cells. This agrees with the finding 
of Lagunoff et al. [24] who detected ORF P in the 
nucleus of cells infected with a mutant which 
overproduced it using immunofluorescence and 
Western-blotting of fractionated cell extracts.
Antisera 128 did not work in immunofluorescence 
due to their high background and thus there was no 
attempt to investigate colocalization of ORF P and 
SC35 by immunofluorescence.
Overall, these results show that ORF P interacts 
with SC35 in vitro and also colocalizes with ORF P 
in the nucleus of infected cells. However, due to 
technical difficulties, we were unable to determine 
if an in vivo interaction was occurring. This data is 
in agreement with the previously published work in 
which using immunofluorescence it was 
demonstrated that ORF P colocalizes with SM 
antigens and SC35 in the nuclei of infected cells, 
interacts with SM components in a GST pulldown 
assay and with p32 in a yeast-two-hybrid system 
[21]. Further works are needed to determine if ORF 
P interacts with SC35 or the other cellular proteins 
in vivo.
Fig. 3. Western-blotting of BHK nuclear and cytoplasmic 
extracts with anti-ORF P serum 128. BHK cells were infected 
with HSV-1 at a m.o.i. of 20 pfu/cell and harvested at 24 h pi. 
Analysis of ORF P distribution in both BHK cell nuclear and 
cytoplasmic extracts was carried out by 12.5% SDS-PAGE and 
Western-blotting with antiserum 128 and protein-A-HRP, 
reacted with ECL and exposed to autoradiography. Lanes 1, 3, 
5 and 7, nuclear extracts; lanes 2, 4, 6 and 8, cytoplasmic 
extracts. Lanes 1 and 2, tsK; lanes 3 and 4, 17+; lanes 5 and 6, 
1716; lanes 7 and 8, MI; lane 9, tsK infected whole cell extract. 
Molecular weight markers are indicated on the right and ORF P 
related bands are marked on the left ().
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